Late cardiotoxicity in MS patients treated with mitoxantrone

Late cardiotoxicity in MS patients treated with mitoxantrone

Context: Mitoxantrone (MTX) is an antracyclin drug that is used for treatment of patients with chronic refractory multiple sclerosis (MS). Congestive heart failure (CHF) is a rare complication of this drug that may occur early, during therapy, or late, months or years after termination of therapy. A...

Full description

Bibliographic Details
Main Authors: Jamshid Najafian, Ali Nasri, Masoud Etemadifar, Fardin Salehzadeh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:International Journal of Preventive Medicine
Subjects:
heart failure
mitoxantrone
multiple sclerosis
Online Access:http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2019;volume=10;issue=1;spage=211;epage=211;aulast=Najafian

Similar Items

Similar Items